Cardiff Oncology, Inc. (CRDF) Income Annual - Discounting Cash Flows
CRDF
Cardiff Oncology, Inc.
CRDF (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2006
01-31
2005
01-31
Report Filing 2025-11-06 2025-02-27 2024-02-29 2023-03-02 2022-02-24 2021-02-25 2020-02-27 2019-03-06 2018-02-26 2017-03-15 2016-03-10 2015-03-12 2014-03-17 2013-04-01 2012-03-30 2010-12-31 2009-12-31 2006-05-16 2005-10-28
Revenue 0.501 0.683 0.488 0.386 0.359 0.366 0.245 0.378 0.505 0.381 0.313 0.28 0.259 0.45 0.258 0.266 0.65 0 0
Cost of Revenue 11.58 0 0 0 0 0 0 0.597 1.81 1.73 0.629 0.015 3.48 1.92 0 0 0 0 0
Gross Profit -11.08 0.683 0.488 0.386 0.359 0.366 0.245 -0.219 -1.31 -1.35 -0.316 0.265 -3.22 -1.47 0.258 0.266 0.65 0 0
Operating Expenses 42.63 49.33 45.9 40.29 29.21 19.45 16.92 16.83 24.29 38.8 24.96 15.21 7.47 3.38 3.23 5.64 3.04 8 5.38
Research & Development 39.97 36.85 32.86 27.11 17.38 11.23 11.16 8.16 7.88 15.01 10.59 6.67 3.95 1.92 0.911 3.69 0 1.88 0.62
Selling, General and Administrative 10.92 12.48 13.04 13.18 11.84 8.22 5.76 8.01 14.23 23 14.36 8.54 7 3.38 2.32 1.95 2.22 2.53 0.652
Other Operating Expenses -8.26 0 0 0 0 0 0 0.664 2.17 0.79 0 0 -3.48 -1.92 0 0 0.82 3.59 4.11
Operating Income -53.7 -48.65 -45.41 -39.9 -28.86 -19.09 -16.68 -17.05 -25.6 -40.15 -25.27 -14.95 -10.69 -4.85 -2.98 -5.38 -2.39 -8 -5.38
Net Non-Operating Interest 3.28 3.26 4.07 1.58 0.264 0.088 0.234 0.194 -0.886 -1.38 -1.47 -0.831 -0.013 0 -0.056 -0.115 0.09 0.129 0
Interest Income 3.28 3.26 4.07 1.58 0.264 0.09 0.234 0.219 0.148 0 0.057 0.012 0.004 0 0 0 0 0.129 0
Interest Expense 0 0 0 0 0 0.002 0 0.025 1.03 1.38 1.53 0.843 0.017 0 0.057 0.116 -0.09 0 0
Equity & Other Income/(Expense) 0.004 -0.039 -0.098 -0.383 0.3 -0.309 0.03 0.398 1.58 2.32 -0.729 1.45 -1.11 -6.72 0.756 0.161 -0.18 0.026 0.006
Income Before Tax -50.42 -45.43 -41.44 -38.7 -28.29 -19.31 -16.41 -16.46 -24.91 -39.2 -27.47 -14.32 -11.81 -11.57 -2.28 -5.33 -2.48 -7.84 -5.37
Income Tax Expense 0 0 0 0 0 0 0 0.618 0.716 -0.296 1.82 0.608 0.017 6.68 -0.738 0.07 -0.18 0 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 -0.618 -0.716 0.296 -1.82 -0.608 -0.017 -6.68 0.699 0.046 0.18 0 0
Net Income -50.42 -45.43 -41.44 -38.7 -28.29 -19.31 -16.41 -16.46 -24.91 -39.2 -27.47 -14.32 -11.81 -11.57 -2.24 -5.45 -2.48 -7.84 -5.37
Depreciation and Amortization 0.912 0.404 0.398 0.236 0.451 0.466 0.494 0.736 1.05 1.07 0.379 0.235 0.131 0.038 0.01 0.008 0.05 0 0
EBITDA -52.79 -48.25 -45.01 -39.67 -28.4 -18.62 -16.18 -16.32 -24.54 -39.08 -24.9 -14.71 -10.56 -4.81 -2.97 -5.37 -2.34 -8 -5.38
Earnings Per Share (EPS) -0.83 -0.95 -0.93 -0.89 -0.73 -1.08 -2.7 -7.06 -51.71 -93.54 -75.49 -54.56 -50.27 -63.87 -16.6 -54.81 -35.43 -7.55 -5.17
Diluted Earnings Per Share -0.91 -0.95 -0.93 -0.89 -0.73 -1.08 -2.7 -7.06 -51.71 -93.22 -74.77 -54.08 -50.09 -63.73 -16.6 -54.81 -35.43 -7.55 -5.17
Weighted Average Shares Outstanding 66.88 47.65 44.68 43.6 39.03 20.88 5.97 2.33 0.482 0.419 0.364 0.263 0.235 0.181 0.135 0.099 0.07 1.04 1.04
Diluted Weighted Average Shares Outstanding 66.88 47.65 44.68 43.6 39.03 20.88 5.97 2.33 0.482 0.421 0.367 0.265 0.236 0.181 0.135 0.099 0.07 1.04 1.04
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program